Vaxcyte annual meeting: directors re-elected, say-on-pay approved, auditor ratified

Vaxcyte, Inc.

Peter Hirth re-elected as Class II director with 44,840,461 votes for, 2,557,604 withheld.
Heath Lukatch re-elected as Class II director with 44,945,210 votes for, 2,452,855 withheld.
Say-on-pay proposal passed with 47,263,430 for, 132,867 against, 1,768 abstentions.
Future say-on-pay frequency set at one year based on 47,358,585 votes for one year.
Deloitte & Touche LLP ratified as auditor for FY2022 with 51,800,260 for, 335 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.